Price

US$ 641,72

variation (12m)

32,57% Logo

p/l

52,40

p/vp

35,40

DIVIDEND YIELD

0,00%
graph

quote IDXX

BVMF
IDXX
If you had invested
If you had invested
year ago
year ago
6 months
1 year
5 years
10 years
today you would have
today you would have:
*The figure considers the reinvestment of dividends.

profitability of IDXX

1 month
3 months
1 year
2 years
5 years
10 years
profitability
1 month
13,54%
3 months
24,77%
1 year
32,57%
2 years
30,15%
5 years
67,12%
10 years
797,89%

real profitability

profitability minus inflation.

1 month
13,54%
3 months
24,15%
1 year
25,96%
2 years
18,64%
5 years
22,11%
10 years
432,30%
Estatistica

Indicators IDXX

check out the fundamentals of IDEXX Laboratories shares

P/L

52,40
Sector: -1,52 Industry: -3,80

P/SALES (PSR)

12,79
Sector: 1,99 Industry: 2,90

P/VP

35,40
Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%
Sector: - Industry: -

ROA

29,59%
Sector: -26,53% Industry: -56,94%

ROE

67,57%
Sector: -31,21% Industry: -45,34%

ROIC

44,76%
Sector: -404,40% Industry: -420,46%

Net Margin

24,41%
Sector: -26,56% Industry: -32,35%

GROSS MARGIN

61,54%
Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

31,09%
Sector: -23,10% Industry: -30,21%

P/EBITDA

37,87
Sector: 0,07 Industry: -2,60

P/EBIT

41,00
Sector: -1,37 Industry: -3,22

P/ASSETS

15,51
Sector: 1,23 Industry: 1,32

VPA

18,24
Sector: 3,66 Industry: 1,68

LPA

12,32
Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,44
Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

8,33%
Sector: - Industry: -

CAGR PROFITS 5 YEARS

11,12%
Sector: - Industry: -
RETORNO DO INVESTIMENTO

FAIR PRICE OF IDEXX Laboratories ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 641,72

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-88,92%
Because it considers equity value in its calculation, the formula does not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
statistics

IDXX indicators history

Checklist do Investidor Buy And Hold

Checklist do investidor buy and hold sobre IDEXX Laboratories

comparator of Stocks

graph

comparison of IDXX with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.
Cotação

dividend history IDXX dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY

Logo IDEXX Laboratories

IDEXX Laboratories Inc.

Average user rating I10

4.0 (18 people)

Estados Unidos

Estados Unidos

42 years

Foundation: 1983

1991

Year of debut on the stock exchange - 34 years

10.350

Employees

Market value

US$ 51,64 Billions

US$ 51,64 Billions

Net worth

US$ 1,46 Billion

US$ 1.458.830.000,00

Assets

US$ 3,33 Billions

US$ 3.330.790.000,00

Total Number of Shares

80,00 Milhões

80.000.000

Average Daily Trading Volume

US$ 611,00 Thousand

US$ 610.998,00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

Shares

receitas e lucros

IDXX revenue and profits

graph

PROFIT X PRICE IDXX

resultados

IDXX results

DRAG THE FRAME TO SEE MORE DATA
Resultados

IDXX cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

evolution of assets - IDXX

Pontos Relevantes

IDXX balance sheet

DRAG THE FRAME TO SEE MORE DATA

Common Questions

What is the price of IDEXX Laboratories (IDXX) today?

The price of IDEXX Laboratories (IDXX) today is R$ 3.490,96, with a variation of 32.57% compared to the last year. The price of IDEXX Laboratories (IDXX) started the year trading around R$ 2.249,11 and today it is at R$ 3.490,96. Follow the real-time price chart, the historical price of IDEXX Laboratories (IDXX), and stock data from Ibovespa and international markets.

When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not distribute dividends in the last year.

IDEXX Laboratories (IDXX) is it worth it?

Currently, IDEXX Laboratories (IDXX) is priced at R$ 3.490,96, with a P/E of 52,40%, representing a deviation of 54,47% from its historical average P/E. In the last year, the stock showed a variation of 32.57% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 32,57%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of IDEXX Laboratories (IDXX)?

Investing in shares of IDEXX Laboratories (IDXX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of IDEXX Laboratories (IDXX) yield today?

The yield of IDEXX Laboratories (IDXX) was 13,54% in the last month, 32,57% in the last year and 67,12% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of IDEXX Laboratories (IDXX) today, the total investment would be based on the current price of R$ 3.490,96.

If past performance were to repeat, the return on your investment would be:

  • In 1 year: R$ 462.796,14
  • In 5 years: R$ 583.408,70
  • In 10 years: 3.134.495,20

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.